Qube Research & Technologies (QRT)
ACHN

Qube Research & Technologies (QRT)’s Achillion Pharmaceuticals ACHN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-633,598
Closed -$3.82M – 1911
2019
Q4 		$3.82M Buy
+633,598
New +$3.67M 0.12% 188

Qube Research & Technologies (QRT)'s ACHN Position: Q1 2020 in Review

Qube Research & Technologies (QRT) sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 633,598 shares — an estimated $3.82M sold.

Qube Research & Technologies (QRT) first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $3.82M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Qube Research & Technologies (QRT) reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 633,598 Achillion Pharmaceuticals shares in Q1 2020, an estimated $3.82M.
  • Qube Research & Technologies (QRT) first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Achillion Pharmaceuticals position peaked at $3.82M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2020, filed 15 May 2020.